Year-end Sale % OFF 
Abstract
Irrespective of their local and systemic adverse effects, conventional corticosteroids remain the foundation of therapy for induction of clinical remission in patients with Crohn’s disease because of their prompt onset of action and effectiveness. However, they are not recommended as maintenance therapy because of their lack of efficacy in maintaining remission and potential to cause systemic adverse effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
